Two men，seated indoors around a table，engaged ina conversation and playing chess

发现频率

Our innovative medicines address society’s greatest disease burdens and restore possibility for patients。
钢轨伸缩装置

展开，展开

Discover how we unravel the mysteries of biology and develop new technologies to fight disease and change lives。
组，组，组，组，组，组，组，组，组，组

左下倾斜，左下倾斜

Creating a medicine is just the beginning of the journey。Discover how we embrace societal impact as a core business objective。
Q12024

Novartis Financial Results–Q12024

Novartis announced the company’s financial results for the first quarter of 2024。

Learn more

Latest news

Apr242024

  • 介质释放，介质释放

地下Venture announce positive efficicacy and safety data for annovel treatment for babies<5kg with malaria

Apr232024

  • 介质释放，介质释放

Novartis radioligand therapy Lutathera®FDA approved as first medicine specifically for pediatric patients with gastroenteropancreatic neuroendocrine tumors

Apr232024

  • 介质释放，介质释放

Novartis delivers double-digit sales growth and core margin expansion in Q1；FY2024 guidance raised
全部，全部

The burden of IgAN

IgAN nephropathy（IgAN）isa heterogeneous，progressive，rare kidney disease and is a major cause of chronic kidney disease worldwide。Novartis is working to slow the progression of this disease and extend a dialysis-free life in patients。

Learn more
Shanelle Gabriel spending time with her father in New York

Novartis in Society Integrated Report2023

Learn about our business，strategy and performance in2023，and how we create sustainable value for stakeholders and society。

查看online summary
Two business people laughing

Welcome to where we thrive together

Working together。Learning together。Thriving together。Discover how you can join us in changing people's lives。

Join us

资源链接

About Novartis
Healthcare Professionals
Patients and Caregivers
Pipeline
产品，产品